Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 13, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 30
- −7 vs. Q2 2023
- Portfolio value
- $200.8M
- −$88.3M (−30.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 331,416 | $18.9M | 9.4% | +29,416+9.7% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 1,489,025 | $18.1M | 9.0% | +163,250+12.3% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 145,357 | $17.6M | 8.8% | +19,900+15.9% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 349,300 | $16.9M | 8.4% | +32,000+10.1% | Added | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 458,659 | $15.8M | 7.9% | +51,800+12.7% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 163,772 | $15.3M | 7.6% | +24,000+17.2% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 556,928 | $12.9M | 6.4% | −51,700−8.5% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 431,693 | $12.7M | 6.3% | +62,600+17.0% | Added | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 563,345 | $12.3M | 6.1% | +70,800+14.4% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 427,000 | $11.8M | 5.9% | +427,000 | New | History |
| ACADAcadia Pharmaceuticals Inc | COM | 556,553 | $11.6M | 5.8% | −290,400−34.3% | Reduced | History |
| ARVNArvinas, Inc. | COM | 504,700 | $9.91M | 4.9% | +93,200+22.6% | Added | History |
| TVTXTravere Therapeutics, Inc. | COM | 895,821 | $8.01M | 4.0% | +134,100+17.6% | Added | History |
| MORFMorphic Holding, Inc. | COM | 325,356 | $7.45M | 3.7% | +37,800+13.1% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 870,870 | $7.32M | 3.6% | +169,300+24.1% | Added | History |
| SLDBSolid Biosciences Inc. | COM NEW | 961,251 | $2.42M | 1.2% | 00.0% | Unchanged | History |
| CLDICalidi Biotherapeutics, Inc. | CL A | 125,000 | $415.6K | 0.2% | +125,000 | New | History |
| Ares Acquisition CorporationG33032122 | *W EXP 99/99/999 | 504,706 | $333.6K | 0.2% | 00.0% | Unchanged | – |
| Bridgetown Holdings LtdG1355U121 | *W EXP 09/30/202 | 895,000 | $304.3K | 0.2% | 00.0% | Unchanged | – |
| Churchill Capital Corp VII17144M110 | *W EXP 02/29/202 | 548,000 | $168.8K | 0.1% | 00.0% | Unchanged | – |
| CLDWWCalidi Biotherapeutics, Inc. | *W EXP 03/14/202 | 655,200 | $144.1K | 0.1% | 00.0% | Unchanged | History |
| Compass Digital Acquisitn CoG2476C123 | *W EXP 09/29/202 | 459,906 | $101.3K | 0.1% | 00.0% | Unchanged | – |
| Churchill Capital Corp VI17143W119 | *W EXP 02/17/202 | 540,000 | $86.4K | <0.1% | 00.0% | Unchanged | – |
| Ross Acquisition Corp IIG7641C114 | *W EXP 02/01/202 | 439,666 | $49.0K | <0.1% | 00.0% | Unchanged | – |
| CNDAWConcord Acquisition Corp II | *W EXP 99/99/999 | 408,333 | $42.6K | <0.1% | 00.0% | Unchanged | History |
| Swiftmerge Acquisition CorpG63836111 | *W EXP 12/13/202 | 490,000 | $34.6K | <0.1% | 00.0% | Unchanged | – |
| Ys Biopharma Co LtdG9845F117 | *W EXP 03/15/202 | 489,999 | $17.1K | <0.1% | 00.0% | Unchanged | – |
| Marblegate Acquisition Corp.56608A113 | *W EXP 08/31/202 | 735,000 | $13.5K | <0.1% | 00.0% | Unchanged | – |
| Churchill Capital Corp V17144T115 | *W EXP 10/29/202 | 612,000 | $0 | 0.0% | 00.0% | Unchanged | – |
| Home Plate Acquisition Corp43734R111 | *W EXP 09/30/202 | 690,000 | $0 | 0.0% | 00.0% | Unchanged | – |
Sold out since Q2 2023 (9)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 241,690 | $22.0M | 7.6% | History |
| SAGESage Therapeutics, Inc. | COM | 357,765 | $16.8M | 5.8% | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 797,527 | $14.4M | 5.0% | History |
| CLVTClarivate PLC | ORD SHS | 1,247,406 | $11.9M | 4.1% | History |
| BHCBausch Health Companies Inc. | Stock | 1,165,000 | $9.32M | 3.2% | History |
| Afternext Healthtech AcquisiG01109126 | *W EXP 99/99/999 | 366,666 | $31.8K | <0.1% | – |
| Conyers Park III Acqsitn Cor21289P110 | *W EXP 08/12/202 | 571,666 | $28.6K | <0.1% | – |
| Bilander Acquisition Corp.09001T114 | *W EXP 05/19/202 | 183,749 | $9.33K | <0.1% | – |
| Corsair Partnering CorpG2540H116 | *W EXP 07/06/202 | 334,666 | $0 | 0.0% | – |